Effects of continuous daily administration of 0.3 mg of norehtindrone on the plasma levels of progesterone and on the urinary excretion of pregnanediol and total oestrogens.
D000284:Administration, Oral; D000328:Adult; D001831:Body Temperature; D002715:Chlormadinone Acetate / Q000494:pharmacology; D004967:Estrogens / Q000652:urine*; D005260:Female; D006801:Humans; D008598:Menstruation / Q000187:drug effects; D009640:Norethindrone / Q000008:administration & dosage*; D010060:Ovulation / Q000187:drug effects; D010507:Periodicity; D011276:Pregnanediol / Q000652:urine*; D011374:Progesterone / Q000097:blood*; D013607:Tablets
D004967:Estrogens; D013607:Tablets; D002715:Chlormadinone Acetate; D011374:Progesterone; D011276:Pregnanediol; D009640:Norethindrone